With abstract notifications going out mid-June and the scientific programme taking shape, now is the time to get excited about Cytokines 2026. The meeting (18–21 October, Scottish Event Campus, Glasgow) will feature plenary and parallel sessions led by field leaders, poster sessions designed for in-depth discussion, and – new this [READ MORE]
I am Tim Nice, Associate Professor of Molecular Microbiology and Immunology at Oregon Health & Science University in Portland, OR. I grew up in rural Wisconsin and like to think that my first training as a biologist came from working with my parents to raise sheep on our farm. I [READ MORE]
I am Hosu Kim, MD. I always make a point of listening to others and learning their perspectives and habits as much as I can. At present, I am conducting translational medicine research as a full-time graduate student at the Seoul National University College of Medicine. Leveraging my research experience [READ MORE]
I am Biljana Riemelmoser, a PhD student at the University of Geneva. My research focuses on skin immunology and the function of Interleukin-38, an understudied cytokine involved in immune barrier regulation. More broadly, I am interested in how host–microbiota interactions regulate skin homeostasis and shape barrier function. I am excited [READ MORE]
ClinicalTrials.gov ID NCT06363370 Sponsor Kexing Biopharm Co., Ltd. Information provided by Kexing Biopharm Co., Ltd. (Responsible Party) Last Update Posted 2024-04-12 Brief Summary To evaluate the efficacy and safety of interferon α1b (GB05) in the treatment of children under 2 years of age with respiratory syncytial virus infection. Detailed Description [READ MORE]
ClinicalTrials.gov ID NCT06368882 Sponsor First Affiliated Hospital of Wenzhou Medical University Information provided by First Affiliated Hospital of Wenzhou Medical University (Responsible Party) Last Update Posted 2024-04-16 Brief Summary This is a prospective, multicenter, open-label, non-randomized controlled real-world study to explore the efficacy and safety and to accumulate more evidence-based [READ MORE]
ClinicalTrials.gov ID NCT06419361 Sponsor First Affiliated Hospital of Chongqing Medical University Information provided by Xiaoyang Zhang, First Affiliated Hospital of Chongqing Medical University (Responsible Party) Last Update Posted 2025-06-04 Brief Summary Stimulator of interferon gene (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING [READ MORE]
The Cytokine Society is proud to announce this year’s most prestigious honors. Christopher Hunter, Ph.D. (University of Pennsylvania) receives the 2026 ICIS–Pfizer Award for Excellence in Interferon and Cytokine Research – the Society’s highest honor – recognizing 35 years of landmark discoveries in IL-27 biology, host–parasite immunity, and cytokine-mediated immune [READ MORE]
A recent study by Ritacco et al from the Gaudet Lab published in Molecular Cell, “The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction”, showed that in living cells, APOL3 couples lysosomal damage to mtDNA efflux and type I IFN production. Their [READ MORE]
I am a translational cancer biologist with a long-standing interest in how interferon signaling and the innate immune system influence tumor behavior. My work focuses on the molecular mechanisms that allow cancer cells to evade immune surveillance, with the goal of identifying new therapeutic strategies. Over the years, my research [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
